- call +1-201-465-4211
- email sales@mrinsights.biz
Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes.
Scope of the Report:
This report focuses on the Injectable Drug Delivery Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Increasing cancer population is the major factor for the growth of the market. Global injectable drug delivery devices market is driven by rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, increasing use of biologics. Technological advancements, improving patient compliance, beneficial reimbursement policies, increasing healthcare awareness and increasing geriatric population has also contributed to the growth of the market. Whereas, risk of blood-borne infections, safety concerns regarding the use of injectable, introduction of the alternative drug delivery devices would restrain the growth of the market.
The worldwide market for Injectable Drug Delivery Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Dickinson and Company
Baxter International
Schott
Eli Lilly
Pfizer
Gerresheimer
Terumo Corporation
Antares Pharma
Novo Nordik
Sanofi
Unilife Corporation
Zogenix
Hospira
Presage Bioscience
MicroCHIPS
Pearl Therapeutics
Genentech
Bend Research
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Devices
Formulation
Market Segment by Applications, can be divided into
Immune Disorder
Cancer
Diabetes
Other
There are 15 Chapters to deeply display the global Injectable Drug Delivery Devices market.
Chapter 1, to describe Injectable Drug Delivery Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Injectable Drug Delivery Devices, with sales, revenue, and price of Injectable Drug Delivery Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Injectable Drug Delivery Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Injectable Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Injectable Drug Delivery Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Injectable Drug Delivery Devices Introduction
1.2 Market Analysis by Type
1.2.1 Devices
1.2.2 Formulation
1.3 Market Analysis by Applications
1.3.1 Immune Disorder
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Dickinson and Company
2.1.1 Business Overview
2.1.2 Injectable Drug Delivery Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dickinson and Company Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Baxter International
2.2.1 Business Overview
2.2.2 Injectable Drug Delivery Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Baxter International Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Schott
2.3.1 Business Overview
2.3.2 Injectable Drug Delivery Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Schott Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Injectable Drug Delivery Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Injectable Drug Delivery Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Gerresheimer
2.6.1 Business Overview
2.6.2 Injectable Drug Delivery Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Gerresheimer Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Terumo Corporation
2.7.1 Business Overview
2.7.2 Injectable Drug Delivery Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Terumo Corporation Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Antares Pharma
2.8.1 Business Overview
2.8.2 Injectable Drug Delivery Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Antares Pharma Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novo Nordik
2.9.1 Business Overview
2.9.2 Injectable Drug Delivery Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novo Nordik Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Injectable Drug Delivery Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Unilife Corporation
2.11.1 Business Overview
2.11.2 Injectable Drug Delivery Devices Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Unilife Corporation Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Zogenix
2.12.1 Business Overview
2.12.2 Injectable Drug Delivery Devices Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Zogenix Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Hospira
2.13.1 Business Overview
2.13.2 Injectable Drug Delivery Devices Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Hospira Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Presage Bioscience
2.14.1 Business Overview
2.14.2 Injectable Drug Delivery Devices Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Presage Bioscience Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 MicroCHIPS
2.15.1 Business Overview
2.15.2 Injectable Drug Delivery Devices Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 MicroCHIPS Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Pearl Therapeutics
2.16.1 Business Overview
2.16.2 Injectable Drug Delivery Devices Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Pearl Therapeutics Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Genentech
2.17.1 Business Overview
2.17.2 Injectable Drug Delivery Devices Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Genentech Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Bend Research
2.18.1 Business Overview
2.18.2 Injectable Drug Delivery Devices Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Bend Research Injectable Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Injectable Drug Delivery Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Injectable Drug Delivery Devices Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Injectable Drug Delivery Devices Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Injectable Drug Delivery Devices Manufacturer Market Share in 2017
3.3.2 Top 6 Injectable Drug Delivery Devices Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Injectable Drug Delivery Devices Market Analysis by Regions
4.1 Global Injectable Drug Delivery Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Injectable Drug Delivery Devices Sales and Market Share by Regions (2013-2018)
4.1.2 Global Injectable Drug Delivery Devices Revenue and Market Share by Regions (2013-2018)
4.2 North America Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
4.3 Europe Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
4.5 South America Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
5 North America Injectable Drug Delivery Devices by Countries
5.1 North America Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries
5.1.1 North America Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)
5.1.2 North America Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)
5.2 United States Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
5.3 Canada Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
5.4 Mexico Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
6 Europe Injectable Drug Delivery Devices by Countries
6.1 Europe Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries
6.1.1 Europe Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)
6.2 Germany Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
6.3 UK Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
6.4 France Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
6.5 Russia Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
6.6 Italy Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
7 Asia-Pacific Injectable Drug Delivery Devices by Countries
7.1 Asia-Pacific Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)
7.2 China Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
7.3 Japan Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
7.4 Korea Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
7.5 India Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
8 South America Injectable Drug Delivery Devices by Countries
8.1 South America Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries
8.1.1 South America Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)
8.1.2 South America Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
8.3 Argentina Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
8.4 Colombia Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
9 Middle East and Africa Injectable Drug Delivery Devices by Countries
9.1 Middle East and Africa Injectable Drug Delivery Devices Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Injectable Drug Delivery Devices Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Injectable Drug Delivery Devices Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
9.3 UAE Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
9.4 Egypt Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
9.5 Nigeria Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
9.6 South Africa Injectable Drug Delivery Devices Sales and Growth Rate (2013-2018)
10 Global Injectable Drug Delivery Devices Market Segment by Type
10.1 Global Injectable Drug Delivery Devices Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Injectable Drug Delivery Devices Sales and Market Share by Type (2013-2018)
10.1.2 Global Injectable Drug Delivery Devices Revenue and Market Share by Type (2013-2018)
10.2 Devices Sales Growth and Price
10.2.1 Global Devices Sales Growth (2013-2018)
10.2.2 Global Devices Price (2013-2018)
10.3 Formulation Sales Growth and Price
10.3.1 Global Formulation Sales Growth (2013-2018)
10.3.2 Global Formulation Price (2013-2018)
11 Global Injectable Drug Delivery Devices Market Segment by Application
11.1 Global Injectable Drug Delivery Devices Sales Market Share by Application (2013-2018)
11.2 Immune Disorder Sales Growth (2013-2018)
11.3 Cancer Sales Growth (2013-2018)
11.4 Diabetes Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Injectable Drug Delivery Devices Market Forecast (2018-2023)
12.1 Global Injectable Drug Delivery Devices Sales, Revenue and Growth Rate (2018-2023)
12.2 Injectable Drug Delivery Devices Market Forecast by Regions (2018-2023)
12.2.1 North America Injectable Drug Delivery Devices Market Forecast (2018-2023)
12.2.2 Europe Injectable Drug Delivery Devices Market Forecast (2018-2023)
12.2.3 Asia-Pacific Injectable Drug Delivery Devices Market Forecast (2018-2023)
12.2.4 South America Injectable Drug Delivery Devices Market Forecast (2018-2023)
12.2.5 Middle East and Africa Injectable Drug Delivery Devices Market Forecast (2018-2023)
12.3 Injectable Drug Delivery Devices Market Forecast by Type (2018-2023)
12.3.1 Global Injectable Drug Delivery Devices Sales Forecast by Type (2018-2023)
12.3.2 Global Injectable Drug Delivery Devices Market Share Forecast by Type (2018-2023)
12.4 Injectable Drug Delivery Devices Market Forecast by Application (2018-2023)
12.4.1 Global Injectable Drug Delivery Devices Sales Forecast by Application (2018-2023)
12.4.2 Global Injectable Drug Delivery Devices Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Injectable Drug Delivery Devices Picture
Table Product Specifications of Injectable Drug Delivery Devices
Figure Global Sales Market Share of Injectable Drug Deliver
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
